Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (12 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← All medicines

Medicine · bench card

Mexiletine Hydrochloride

As of 02 Nov 2026 11:10 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.

Latest England safety alertNatPSA/2022/007/MHRA · issued 04 Aug 2022 (1551 days ago)
Expected backno date stated by the source in the latest recorded notice
Protocolno Serious Shortage Protocol matched to this name on the NHSBSA register
Scotlandno NHS Scotland alert matched to this name (separate record)

Presentations, as stated in the latest recorded notice

No product lines could be read from the latest recorded notice for this medicine, so no presentation-level status is shown. The notice itself is listed in the history below.

Protocol in force

No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.

Named in the source as remaining available

The latest recorded notice names no alternative as remaining available.

Identifiers — Mexiletine Hydrochloride

Also known as
Mexiletine 100mg tablets · Mexiletine 10mg/5ml oral solution · Mexiletine 200mg/5ml oral solution · Mexiletine 250mg/10ml solution for injection ampoules · Mexiletine 25mg capsules · Mexiletine 360mg modified-release capsules · +12 more
BNF chemical
Mexiletine hydrochloride 0203020P0 — matched on a generic name
Class
Drugs for arrhythmias · Anti-arrhythmic drugs · Cardiovascular System
SNOMED codes
12963411000001109, 12963811000001106, 13008311000001108, 13008411000001101, 15446711000001104 and 34 more
Suppliers named in the NHSBSA dataset
A A H Pharmaceuticals Ltd · Alliance Healthcare (Distribution) Ltd · Boehringer Ingelheim Ltd · Colonis Pharma Ltd · Lupin Healthcare (UK) Ltd · Sovereign Medical Ltd · +1 more (from the dataset, not from the notices)

BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.

BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

History

One supply notification on record, 04 Aug 2022. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.

Also recorded under

No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.

Scotland — separate record

No NHS Scotland Medicine Supply Alert Notice on record matches this name. Scotland is a separate record (all Scotland alerts); absence here is not a statement about supply in Scotland.

Last checked
20 Oct 2026 — sources are checked twice daily by scheduled jobs, not continuously
Last source change
19 Oct 2026
Latest notice captured
23 Feb 2024
Sources
Latest notice post ↗https://cpe.org.uk/our-news/national-patient-safety-alert-class-1-medicines-recall-notification-mexiletine-hydrochloride-50mg-100mg-200-mg-hard-capsules-clinigen-healthcare-ltd · methodology · corrections log

Re-expressed facts with links to the source documents; roles are inferred from phrasing and flagged; fuzzy dates stay fuzzy. Not an official NHS or DHSC service and not clinical advice — in a shortage, follow the guidance issued to your pharmacy or prescriber. Absence of a record is never availability.